Colorectal cancer trials in Argentina

In Argentina 16 Also abroad 1930

16 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Where
Buenos Aires, Caba, Ciudad Autónoma de Buenos Aires, Córdoba, La Rioja
Age
18 years and over
People
430 worldwide
Run by
Pfizer
See details and how to joinNCT04557449 · EU 2024-512120-11-00
Phase 3Taking people
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Where
Ciudad Autonoma Buenos Aires, Rosario, San Juan, San Miguel de Tucumán
Age
18 years and over
People
1,020 worldwide
Run by
EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07549412 · EU 2025-524648-37-00
Phase 3Taking people
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Where
Berazategui, Ciudad Autonoma de Buenos Aires, Córdoba, Mar del Plata, Rosario
Age
18 years and over
People
477 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06997497 · EU 2024-517232-22-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Where
Buenos Aires, Ciudad Autonoma Buenos Aires, Córdoba, La Rioja, Mar del Plata, Rosario, San Miguel de Tucumán
Age
18 years and over
People
700 worldwide
Run by
Incyte Corporation
See details and how to joinNCT07284849 · EU 2025-523735-19-00
Phase 1/2Taking people
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Where
Buenos Aires, Caba, Ciudad Autonoma Buenos Aires, Mar del Plata
Age
18 years and over
People
680 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00
Phase 2/3Taking people
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Where
ABB, Buenos Aires, CABA, Ciudad Autónoma de Buenos Aires, Córdoba, San Miguel de Tucumán
Age
18 years and over
People
990 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07221357 · EU 2025-523224-45-00
Phase 2Taking people
A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
Where
Bariloche, Buenos Aires, Córdoba, Mar del Plata, Rosario
Age
18 years and over
People
140 worldwide
Run by
Vividion Therapeutics, Inc.
See details and how to joinNCT07811193 · EU 2026-525507-26-00
Phase 3Taking people
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Where
Córdoba, La Rioja, Pergamino, Pilar, San Miguel de Tucumán
Age
18 years and over
People
800 worldwide
Run by
Pfizer
See details and how to joinNCT07222800 · EU 2025-523521-18-00
Phase 3Taking people
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Where
Buenos Aires, CABA, Ciudad Autonoma de Buenos Aires, Córdoba, La Plata, La Rioja, Mar del Plata, San Miguel de Tucumán, Viedma
Age
18 years and over
People
450 worldwide
Run by
Amgen
See details and how to joinNCT06252649
Phase 3Taking people
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Where
Buenos Aires, CABA, Córdoba, Pergamino, Rosario
Age
18 years and over
People
400 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05253651 · EU 2024-514180-25-00
No phaseTaking people
Epidemiological and Molecular Colorectal Cancer Registry
Where
CABA
Age
21 years to 96 years
People
2,100
Run by
Hospital Italiano de Buenos Aires
See details and how to joinNCT02781337
Phase 3Taking people
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Where
Buenos Aires, Capital Federal, Ciudad Autonoma de Buenos Aire, Córdoba, Mar del Plata, Rosario, San Miguel de Tucumán, Santa Fe
Age
18 years and over
People
892 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT05855200 · EU 2023-503265-27-00
No phaseTaking people
The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
Where
Rosario
Age
40 years to 75 years
People
6,000 worldwide
Run by
Javier Toledo
See details and how to joinNCT06717295
No phaseTaking people
Colon Cancer Liquid Biopsy Investigation of Methylation-based Biomarkers Evaluation Using Delta-HLD (CLIMBED)
Where
Mendoza
Age
45 years to 75 years
People
3,200
Run by
Epiliquid Holding, Inc
See details and how to joinNCT07168876
No phaseTaking people
Colorectal Analysis for Signature Cancer Assessment Using Delta-HLD
Where
Mendoza
Age
45 years to 75 years
People
600
Run by
Epiliquid Holding, Inc
See details and how to joinNCT07148297
No phaseTaking people
Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait
Where
Buenos Aires
Age
18 years and over
People
216 worldwide
Run by
Hospital Alemão Oswaldo Cruz
See details and how to joinNCT05000697